Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences.
Israel already boasts the world's biggest generic drug maker and a host of smaller research-oriented companies. Now it aims to build on that foundation, offering incentives to multinational businesses to invest in a biopharmaceutical incubator fund, set up research centers and collaborate with local firms.
To read the original article: Israel Hayom | After tech success, Israel seeks to kickstart life sciences growth
